Haohai Bio to host semi-annual earnings briefing for STAR market investors

Shanghai Haohai Biological Technology Co., Ltd. will participate in the 2025 semi-annual STAR Market Biological Products and CXO Industry Collective Earnings Briefing. The event is scheduled for Monday, September 15, 2025, from 3:00 PM to 5:00 PM, and will be conducted via video livestream and online interaction on the Shanghai Stock Exchange's "SSE Roadshow Center" (http://roadshow.sseinfo.com).

The briefing follows the release of the company's 2025 semi-annual report on August 23, 2025. To enhance communication, investors are encouraged to submit questions in advance between September 8, 2025, and September 12, 2025, at 4:00 PM, either through the "Pre-collection of Questions" section on the SSE Roadshow Center homepage or via email at info@3healthcare.com. The company will address common investor questions during the briefing.

Key attendees from the company will include chairman Hou Yongtai, executive director and general manager Wu Jianying, executive director and cfo Tang Minjie, executive director Chen Yiyi, independent director Shen Hongbo, and board secretary Tian Min.